Press Releases
May 17, 2021

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") will share new data across its oncology portfolio during the 2021 American Society of Clinical Oncology...

May 13, 2021

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced Japan's Ministry of Health, Labour and Welfare (MHLW) has granted priority review for the...

May 4, 2021

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the European Commission (EC) has approved an additional indication for the oral...

EXPLORE ALL US PRESS RELEASES

Articles
Sep 17, 2020

As part of our ranking among Working Mother Magazine’s Top 10 companies and among the top 30 for working dads, we selected Dominique Talbert, director Scientific Publications, Medical &...

May 14, 2021

To further our mission to meet patients’ unmet medical needs through innovative pharmaceutical products, we recently announced several strategic executive promotions in the Quality Assurance...

Mar 7, 2019

An Interview with Astellas US President Percival Barretto-Ko recently shared his day-to-day experience in his role as well as some of the key focus areas that are critical to the future of...

EXPLORE ALL ARTICLES

Stay Connected

Get only the email alerts you want.

Subscribe

Media Contacts

corporate.communications@astellas.com

800-888-7704
(press menu option 5, then option 2)
This line is monitored between 8:00am-4:30-pm Central Time M-F

For inquiries during non-business hours, please contact us

 

Astellas on Twitter
Download Fact Sheet
Sustainability
Investors
Explore U.S. Products